Eris Lifesciences Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| EBITDA | 439 | 511 | 0 |
| EBIT | 396 | 446 | 0 |
| Earning Per Share | 26 | 29 | 28 |
| Expenses | 781 | 862 | 1,148 |
| Net Profit | 355 | 406 | 374 |
| Net Profit Margin | 29 | 30 | 22 |
| Operating Profit Margin | 36 | 38 | 33 |
| Profit Before Tax | 394 | 442 | 405 |
| Dividends Per Share | 6 | 6 | 0 |
| Operation Revenue | 1,221 | 1,373 | 1,696 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 80.62 | NA | 86.80 | |
| 2022 | 1,739.20 | 2,486.90 | 993.60 | 9,042.13 | 1,441.20 | |
| 2023 | 0 | 0 | 447.69 | NA | 716.49 | |
| 2023 | 0 | 0 | 4,470.30 | NA | 6,011.50 | |
| 2023 | 0 | 0 | 8,560.84 | NA | 9,408.43 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2018 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|
| Operating Activities | 235 | 223 | 271 | 375 | 292 |
| Investing Activities | -590 | -5 | 123 | -323 | -982 |
| Financing Activities | 363 | -221 | -335 | -82 | 688 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 8 | -3 | 60 | -30 | -2 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2022 | -17.75 | 18.85 | -5.82 | -4.72 | |
| 2023 | 625.39 | -528.49 | -77.46 | 19.45 | |
| 2020 | 1,468.84 | 1,106.99 | -890.58 | 1,685.25 | |
| 2023 | 5,887.50 | -4,137.30 | -2,686.10 | -935.90 | |
| 2023 | 4,959.33 | -7,943.68 | 2,376.07 | -608.28 |
Financials
All values are in Rs Cr